Contact
Please use this form to send email to PR contact of this press release:
Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myeloma
TO:
Please use this form to send email to PR contact of this press release:
Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myeloma
TO: